Workshop on regulatory support for development of orphan medicines

23 November 2020 - On Monday, 30 November, EMA is hosting a workshop to discuss the benefits and impact of ...

Read more →

Politics, science and the remarkable race for a coronavirus vaccine

21 November 2020 - The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical ...

Read more →

Oxford developed COVID-19 vaccine, then scholars clashed over money

21 October 2020 - Early deal with Merck was scotched for fear poor countries would be left out; now university could ...

Read more →

EMA cancer symposium: new approaches in patient-focused cancer medicine development

15 October 2020 - On Thursday, 29 October, EMA is hosting a symposium to discuss new approaches to facilitating and ...

Read more →

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

8 October 2020 - US drug prices are the highest in the world and are continuing to rise, with an increasing ...

Read more →

Biotech industry pushes Trump Administration to release new vaccine guidelines

2 October 2020 - The BIO trade group, whose members include most of the vaccine makers, asked the health secretary to ...

Read more →

Pfizer CEO on the pressures of creating a COVID-19 vaccine: ‘what is at stake is beyond imagination'

30 September 2020 - Albert Bourla, 58, is chairman and chief executive of Pfizer, a multinational pharmaceutical company. Bourla is a ...

Read more →

'Pharma resistance’ to battle superbugs

24 September 2020 - A group of pharmaceutical ­giants, biotech companies, industry peak bodies and the CSIRO have banded together ...

Read more →

New early scientific advice service to support medicine registrations

22 September 2020 - The Therapeutic Goods Administration has launched a new initiative - the Early Scientific Advice service - ...

Read more →

The antibiotic paradox: why companies can’t afford to create life-saving drugs

19 August 2020 - Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival ...

Read more →

Trials of a vaccine and new drug raise hope of beating COVID-19

20 July 2020 - The latest tests with Oxford University’s vaccine, and interferon beta, look promising. ...

Read more →

Many drug companies working on COVID-19 vaccines and treatments are lobbying harder than usual

20 July 2020 - Pharmaceutical companies racing to develop coronavirus treatments and vaccines have upped their lobbying presence in the ...

Read more →

Deep dive into big pharma AI productivity: one study shaking the pharmaceutical industry

15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from ...

Read more →

The COVID-19 vaccine development multiverse

14 July 2020 - Leaving in its wake more than 12 million infections, over 550,000 deaths, and an economic toll in ...

Read more →

WHO takes stock of global COVID-19 R&D progress

6 July 2020 - Researchers and developers meet virtually to discuss progress. ...

Read more →